USANA (USNA) Q2 2026 earnings review
Omnichannel Growth Strategy Hits a Brick Wall
USANA's strategic pivot to diversify away from its stagnant core direct-selling business suffered a severe blow this quarter. The two venture brands intended to drive all near-term growth—Hiya and Rise Wellness—dramatically underperformed, forcing management to slash full-year guidance and take a $29.1 million goodwill impairment on Hiya. Total net sales declined 5% YoY to $223 million, but the real shock was the profitability collapse: GAAP EPS swung to a $(1.16) loss, and Adjusted EBITDA fell 9% YoY. While the balance sheet remains pristine ($169M cash, zero debt), the narrative that acquired retail/DTC brands will quickly offset core legacy declines has been broken.
🐂 Bull Case
USANA ended the quarter debt-free with $169 million in cash. They generated $20 million in free cash flow, giving them ample runway to weather this transition and aggressively pursue in-house manufacturing cost savings.
The legacy Core Nutritional segment showed modest resilience. Despite a 4% YoY revenue decline, China grew 1% YoY, marking its second consecutive quarter of positive growth.
🐻 Bear Case
Hiya revenue dropped 17% YoY and active subscribers are fleeing. Rise Wellness saw revenue plummet 75% sequentially from Q1, exposing massive execution risks in their retail strategy.
Consolidated margins are under heavy pressure. Rise Wellness operated at a disastrous 10.8% gross margin this quarter, dragging down overall profitability as the company shifts to lower-margin wholesale channels.
⚖️ Verdict: 🔴🔴
Strong Bearish. The fundamental thesis for holding USANA was that Hiya and Rise would provide a bridge to omnichannel growth. Taking a $29M impairment on Hiya and watching Rise's revenue evaporate sequentially completely invalidates management's previous growth narrative.
Key Themes
Hiya's Reversing Trajectory & Massive Impairment
Hiya was supposed to be the DTC crown jewel, but it is rapidly reversing. Active Monthly Subscribers fell 17% YoY to 166,000, continuing a multi-quarter bleed (down from 200.4K a year ago). Elevated customer acquisition costs, driven by disruptions in Meta's advertising environment, are destroying unit economics. The result: a devastating $29.1M non-cash goodwill impairment just a short time after acquisition, reflecting structurally lower near-term forecasts.
Rise Wellness Retail Mirage
Management continues to claim 'underlying demand' for Rise Wellness, but the data screams otherwise. After an explosive Q1 2026 ($13.7M revenue) driven by a Costco channel fill, Q2 revenue collapsed 75% sequentially to just $3.4M. Worse, gross margin for the segment imploded to 10.8% (from 34.9% in Q1). Management blamed a 'packaging-related disruption,' but the sheer magnitude of the sequential drop strongly suggests poor end-consumer sell-through at retail.
Leveraging Legacy Assets for Margin Rescue
USANA's primary operational driver is insourcing its venture brands to rescue their margins. By bringing Hiya and Rise packaging/manufacturing into USANA's legacy facilities, the company expects to generate incremental margin efficiencies in the second half of 2026. Given Rise's current 10.8% gross margin, this operational execution is critical to stop the bleeding.
Targeted Product Innovation: 'Glow'
The company continues to lean into product innovation to stabilize the core. In Q2, USANA launched 'Glow', its first skin-health supplement utilizing cellular-level formulations rather than topical applications. Extending the brand's innovation into adjacent, high-margin categories remains a core tactic to retain aging Direct Selling brand partners.
Macro Advertising Headwinds
The company specifically called out a 'challenging digital marketing environment' pressuring Hiya. Changes in the Meta/social media advertising algorithms have structurally elevated Customer Acquisition Costs (CAC). If DTC metrics cannot be optimized, Hiya's entire subscription-based business model faces a permanent margin ceiling.
Core Market Resilience in China
Greater China remains the bedrock, generating $114.6M in Q2 (51% of total sales). This segment actually grew 1% YoY (constant currency: -3%). In a quarter marred by venture failures, the stabilization of the legacy MLM business in its largest market prevents a complete top-line collapse.
Other KPIs
The gross margin disparity highlights the strategic friction in USANA's transition. While Core margins remain elite (81.1%), the shift toward Rise's wholesale retail model is destroying consolidated gross margins. Rise's margin completely decelerated from Q1 due to 'sub-optimal production yields' and a higher concentration of retail sales.
Despite the net loss, the company generated healthy cash flow driven by working capital management, notably decreasing inventory by 12% ($13M) since year-end 2025. This cash generation allows USANA to fund its transformation without tapping debt markets.
Guidance
Decelerating. Slashed from the prior range of $925M-$1.0B. Represents a substantial downgrade mid-year, primarily driven by the catastrophic drop in expectations for the new venture brands.
Reversing. Drastically cut from the prior $140M-$155M range. Down from $132M in FY25. What was projected as a double-digit growth engine is now officially guided to contract YoY.
Decelerating. Cut nearly in half from the previous $65M-$80M range. This implies minimal subsequent revenue for the rest of the year following the $13.7M printed in Q1, signaling stalled retail sell-through.
Decelerating violently. Slashed from $1.95-$2.29. The leverage in the business model is working heavily in reverse. Lower venture volumes and fixed SG&A investments are crushing the bottom line.
Decelerating. Cut from $101M-$109M. The company cannot cut operating expenses fast enough to match the top-line deterioration of its acquired brands.
Key Questions
Rise Wellness Sell-Through Reality
With Rise guidance slashed by roughly 50% and Q2 revenue dropping 75% sequentially, what is the actual consumer sell-through data at Costco and Walmart indicating? Are we facing a scenario where products will be returned or heavily discounted?
Hiya Impairment Timeline
You recorded a $29.1M goodwill impairment on Hiya based on 'updated valuation assumptions and near-term forecasts.' Given how recently this asset was acquired, what specifically broke in your diligence regarding customer acquisition costs?
Meta Algorithm Dependency
You cite digital marketing headwinds (Meta) for Hiya's subscriber decline. What tangible pivots are being made to diversify customer acquisition away from social media, and how long until those channels scale?
Rise Gross Margin Path
Rise Wellness posted an abysmal 10.8% gross margin. Even with USANA taking over manufacturing, what is the realistic terminal gross margin for this wholesale retail business, and can it ever be accretive to consolidated margins?